16 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2013 ACCF/AHA Guideline ... American College of Cardiology ... Task Force on Clinical ... #cardiology #treatment ... #algorithm #sCHF
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Antiarrhythmic #Drugs #Medications ... #Pharmacology # ... Cardiology #Table
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... Heart Failure #sCHF ... Systolic #HFrEF #Algorithm ... #Management #Cardiology ... #ivabradine #Medications
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... /diagnosis and treatment ... Diagnosis #HFrEF #sCHF ... #HeartFailure #Cardiology ... #Indications #Treatment
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... getting patients on medication ... #sCHF #HeartFailure ... #HFrEF #Pharmacology ... #StageC #Cardiology
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Algorithm Diagnosis ... iron #deficiency #CHF ... #cardiology #treatment ... #guidelines
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
Practice Guideline ... with ‘treatment ... EBM #Management #Pharmacology ... Personality #Disorder #Medications ... Effectiveness #Table
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Dosing: 250 mcg tablet ... recommendations for the treatment ... the use of this medication ... won’t have any clinical ... #Pharmacology #
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... pulmonary disease or CHF ... #Tachycardia #Treatment ... #management #cardiology ... #algorithm